Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

S Espiard1, M-C Vantyghem1, R Desailloud2

  • 1Service d'endocrinologie et métabolisme, hôpital C. Huriez, CHRU de Lille, rue Polonovski, 59037 Lille Cedex, France.

Annales D'Endocrinologie
|November 22, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phenotypic characterization of a new case of multiple endocrine neoplasia type 4 associated with de novo germline and somatic CDKN1B pathogenic variants.

Annales d'endocrinologie·2025
Same author

Endocrinology of bone mineralization: An update.

Annales d'endocrinologie·2021
Same author

[Pheochromocytomas and paragangliomas in pregnancy: About four cases and key messages on management].

Gynecologie, obstetrique, fertilite & senologie·2021
Same author

Multiple Endocrine Neoplasia Type 4: Novel CDNK1B variant and immune anomalies.

Annales d'endocrinologie·2020
Same author

Association of transcription factor 7-like 2 gene (TCF7L2) polymorphisms with stress-related hyperglycaemia (SRH) in intensive care and resulting outcomes: The READIAB study.

Diabetes & metabolism·2019
Same author

Cardiometabolic assessment of lamin A/C gene mutation carriers: a phenotype-genotype correlation.

Diabetes & metabolism·2018
Same journal

Corrigendum to 'Pink adipose tissue: A paradigm of adipose tissue plasticity' [Ann. Endocrinol. 85 (2004) 248-51].

Annales d'endocrinologie·2026
Same journal

Intraoperative location of parathyroid glands during total thyroidectomy: a systematic review of the literature according to the PRISMA method.

Annales d'endocrinologie·2026
Same journal

Clinical and genetic diagnosis of PHP1A associated with hypogonadism in a young male: A case report.

Annales d'endocrinologie·2026
Same journal

Autoimmune features in acquired generalized lipodystrophy and anti-perilipin 1 antibodies: A case report.

Annales d'endocrinologie·2026
Same journal

The diagnostic challenge of occult glucocorticoid exposure causing Cushing's syndrome.

Annales d'endocrinologie·2026
Same journal

ACTH-dependent Cushing's syndrome in MEN1: When multiple tumors complicate the diagnosis.

Annales d'endocrinologie·2026
See all related articles

Parathormone (PTH) regulates calcium. Hypoparathyroidism (hypoPT), a rare disease from decreased PTH, causes various symptoms. Treatment includes supplements and recombinant PTH injections for better control.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Calcium Homeostasis

Background:

  • Parathormone (PTH) is crucial for calcium balance.
  • Hypoparathyroidism (hypoPT) is a rare endocrine disorder characterized by insufficient PTH production.
  • This condition significantly impacts multiple organ systems and reduces quality of life.

Purpose of the Study:

  • To summarize current knowledge on the etiologies, epidemiology, clinical manifestations, and management of hypoparathyroidism.
  • To provide an overview of both acquired and congenital causes of hypoPT.
  • To discuss evolving treatment strategies beyond conventional calcium and vitamin D supplementation.

Main Methods:

  • Review of current literature on hypoparathyroidism.
  • Analysis of epidemiological data.
Keywords:
HypocalcemiaHypocalcémieHypoparathyroidismHypoparathyroïdieParathormoneVitamine D

Related Experiment Videos

  • Synthesis of clinical findings and treatment outcomes.

    • Main Results:

    • HypoPT presents with diverse symptoms affecting multiple organs.
    • Acquired causes, notably thyroidectomy, and congenital genetic defects are key etiologies.
    • Standard treatment involves calcium and active vitamin D, with recombinant PTH offering an alternative for refractory cases.

    Conclusions:

    • Hypoparathyroidism is a complex rare disease with significant morbidity.
    • Understanding diverse etiologies is vital for accurate diagnosis.
    • Emerging therapies like recombinant PTH offer new hope for patients with suboptimal response to conventional treatments.